Biogen Still Soaring Thanks to Alzheimer Breakthrough
If you've contemplated investing in biotech, Biogen Inc (NASDAQ:BIIB) certainly makes the case for this buoyant sector. Biogen stock has gained over 11.0% in the past six months after a bearish phase. Just over a year ago, BIIB stock hit its all-time high of $475.98. But shares plummeted after the company cooled investor sentiment with weak guidance for the second quarter of 2015.
Now Biogen stock is rising, having gained 2.2% in the past week on rather.
Den vollständigen Artikel lesen ...
If you've contemplated investing in biotech, Biogen Inc (NASDAQ:BIIB) certainly makes the case for this buoyant sector. Biogen stock has gained over 11.0% in the past six months after a bearish phase. Just over a year ago, BIIB stock hit its all-time high of $475.98. But shares plummeted after the company cooled investor sentiment with weak guidance for the second quarter of 2015.
Now Biogen stock is rising, having gained 2.2% in the past week on rather.
Den vollständigen Artikel lesen ...